Inactive Instrument

Pfizer Inc Share Price Nyse

Equities

Pharmaceuticals

End-of-day quote Nyse
- USD - Intraday chart for Pfizer Inc
Sales 2024 * 60.41B 4,770B Sales 2025 * 62.71B 4,952B Capitalization 164B 12,942B
Net income 2024 * 7.78B 614B Net income 2025 * 11.29B 891B EV / Sales 2024 * 3.67 x
Net Debt 2024 * 58.11B 4,589B Net Debt 2025 * 49.97B 3,946B EV / Sales 2025 * 3.41 x
P/E ratio 2024 *
20.1 x
P/E ratio 2025 *
14.1 x
Employees -
Yield 2024 *
5.78%
Yield 2025 *
5.88%
Free-Float 59.05%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 62 31/12/92
Director of Finance/CFO 59 01/05/22
Chief Tech/Sci/R&D Officer - 30/06/19
Members of the board TitleAgeSince
Director/Board Member 66 31/03/20
Director/Board Member 64 22/02/17
Director/Board Member 60 26/09/13
More insiders
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company